Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences
Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital
Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan
Baird Medical Investment (NASDAQ:BDMD) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass